Cytochrome P450 Enzymes: |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|
Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|
hsa04727 | GABAergic synapse_Homo sapiens_hsa04727 | 1.686E-07 | 1.416E-05 | GABBR1; GABRR1; SLC6A11; SLC6A1 |
hsa04024 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.998E-04 | 5.594E-03 | GABBR1; NFKB1; TSHR |
hsa00591 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.328E-04 | 5.577E-03 | CYP3A4; CYP2C19 |
hsa04080 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 5.270E-04 | 1.107E-02 | GABBR1; GABRR1; TSHR |
hsa00982 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 7.571E-04 | 1.272E-02 | CYP3A4; CYP2C19 |
hsa05032 | Morphine addiction_Homo sapiens_hsa05032 | 1.312E-03 | 1.574E-02 | GABBR1; GABRR1 |
hsa05204 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.067E-03 | 1.494E-02 | CYP3A4; CYP2C19 |
hsa04210 | Apoptosis_Homo sapiens_hsa04210 | 3.067E-03 | 3.220E-02 | LMNA; NFKB1 |
hsa05202 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 5.010E-03 | 4.676E-02 | KMT2A; NFKB1 |
ICD10 Disease Category | Disease Name | ICD10 Code | Linked Targets |
---|---|---|---|
W85-W99: Exposure to electric current, radiation and extreme ambient air temperature and pressure | Diagnostic test to differentiate primary and secondary hypothyroidism | W88 | TSHR |
C00-D49: Neoplasms | Myeloma | C90 | SLC6A1 |
C00-D49: Neoplasms | Cancer | C00-C96 | NFKB1 |
C00-D49: Neoplasms | Thyroid cancer diagnosis | C73 | TSHR |
E00-E89: Endocrine, nutritional and metabolic diseases | Type 2 diabetes | E11 | NFKB1 |
C00-D49: Neoplasms | Thyroid cancer | C73 | TSHR |
E00-E89: Endocrine, nutritional and metabolic diseases | Fabry's disease | E75.2 | GLA |
R00-R99: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified | Convulsions | R56.0 | SLC6A1 |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Anxiety disorder | F32, F40-F42 | CYP3A4 |